omniture
logo
Search
璧辰（上海）医药科技有限公司 ABM THERAPEUTICS SHANGHAI COMPANY LIMITED
Media Room

Photo News

rss
ABM Therapeutics Receives IND Approval in China for BRAF Inhibitor ABM-1310

ABM Therapeutics Receives IND Approval in China for BRAF Inhibitor ABM-1310

2021-11-30 13:00 1468
ABM Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of ABM-1310 in the USA

ABM Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of ABM-1310 in the USA

2020-06-22 23:00 3482